CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1).

1415559-43-1

C26H21N5O4S

499.54

DMSO:25 mg/mL (50.05 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years